PhRMA boss sees potential for 'golden era' in medical discovery

Stephen Ubl, president and chief executive of the trade group Pharmaceutical Research and Manufacturers of America (PhRMA), is optimistic that the association’s series of policy proposals can help to prompt a bright new period in drug discovery.

Mr Ubl was speaking at the 2016 Annual Meeting of PhRMA, which represents biopharmaceutical research companies in the USA.

“I am a passionate believer in the power of biomedical innovation to save and improve lives," he said, adding: "We are on the cusp of a golden era in medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we can't take this progress for granted. Now is the time for PhRMA to play a leadership role in advancing pragmatic, pro-consumer policies that enhance the private market and address costs holistically."